Table 5 Subgroup analysis of mean differences from the control group (treatment effect)^* at the 1-year follow-up by baseline body weight category, sex and age

1.1 (0.8 to 1.5)^c

1.2 (0.2 to 2.1)^a

1.0 (0.3 to 1.7)^b

1.0 (0.7 to 1.4)^c

1.2 (0.7 to 1.7)^c

1.0 (0.7 to 1.4)^c

1.2 (0.7 to 1.7)^c

0.2 (−0.3 to 0.7)

0.4 (−1.4 to 2.1)

−1.2 (−2.8 to 0.3)

−0.2 (−0.8 to 0.4)

0.2 (−0.5 to 1.0)

−0.3 (−0.9 to 0.3)

0.04 (−0.7 to 0.8)

−0.10 (−1.67 to −0.41)^b

−0.08 (−0.24 to 0.07)

−0.12 (−0.23 to 0.002)

−0.11 (−0.16 to −0.05)^c

−0.06 (−0.21 to 0.02)

−0.17 (−0.25 to −0.09)^c

−0.05 (−0.12 to 0.02)

−1.0 (−1.6 to −0.4)^b

−0.9 (−2.3 to 0.5)

−1.1 (−2.1 to −0.04)^a

−0.9 (−1.4 to −0.4)^c

−1.1 (−2.0 to −0.1)^a

−1.5 (−2.2 to −0.8)^c

−0.5 (−1.1 to 0.1)

−0.4 (−0.7 to −0.02)^a

−0.2 (−1.3 to 0.9)

−1.6 (−2.7 to −0.5)^b

−0.6 (−1.0 to −0.2)^b

−0.4 (−0.9 to 0.2)

−0.7 (−1.0 to −0.3)^b

−0.5 (−1.0 to 0.03)

0.5 (0.2 to 0.8)^b

0.6 (−0.2 to 1.4)

0.1 (−1.0 to 0.7)

0.3 (−0.01 to −0.6)^a

0.6 (0.1 to 1.0)

0.2 (−0.2 to 0.6)

0.5 (0.2 to 0.9)^b

−9.5 (−11.4 to −7.6)^c

−9.3 (−15.0 to −3.7)^b

−17.4 (−22.7 to −12.0)^c

−12.4 (−14.4 to −10.4)^c

−4.5 (−7.8 to −1.2)^b

−6.6 (−8.9 to −4.3)^c

−5.7 (−7.8 to −3.6)^c

−5.2 (−6.9 to −3.6)^c

−9.6 (−14.0 to −5.1)^c

−15.3 (−19.7 to −10.9)^c

−8.0 (−9.7 to −6.2)^c

−5.1 (−8.1 to −2.1)^b

−14.1 (−16.3 to −11.6)^c

−8.7 (−10.8 to −6.6)^c

7.8 (6.1 to 9.4)^c

8.8 (5.3 to 12.3)^c

9.1 (6.4 to 11.8)^c

7.7 (6.3 to 9.1)^c

9.0 (6.4 to 11.6)^c

7.6 (5.8 to 9.4)^c

8.6 (7.0 to 10.3)^c